Products from LC Laboratories

LC Laboratories

LC Laboratories from Woburn, Massachusetts is manufacturing small-molecule reagents since 1980. Numerous reagent vendors sell LC Laboratories' top-quality products under their own labels. If you do signal transduction, oncology or other pre-clinical research, you have probably been relying on LC Labs products, directly or indirectly, from the time you started your research.

More information at: www.lclabs.com

3 from 12 pages
No results were found for the filter!
Tofacitinib, Free Base (Tasocitinib, CP-690550, Xeljanz, CAS 477600-75-2), >99%
Tofacitinib, Free Base (Tasocitinib, CP-690550, Xeljanz,...

Item number: LC-T-1377_200mg

Soluble in DMSO at 100 mg/mL, soluble in ethanol at 100 mg/mL, very poorly soluble in water, maximum solubility in plain water is estimated to be about 10-20 µM, buffers, serum, or other additives may increase or decrease the aqueous solubility
Application: JAK3 inhibitor
CAS 477600-75-2
MW: 312,37 D
From 94.00€ *
Review
Tofacitinib, Citrate Salt (Tasocitinib Citrate, CP-690550 Citrate, CP-690550-10, Xeljanz, CAS 540737
Tofacitinib, Citrate Salt (Tasocitinib Citrate, CP-690550...

Item number: LC-T-1399_1g

Soluble in DMSO
Keywords: Tofacitinib citrate,...
Application: JAK inhibitor
CAS 540737-29-9
MW: 504,49 D
From 94.00€ *
Review
Thiazovivin, Free Base (Tzv, CAS 1226056-71-8), >99%
Thiazovivin, Free Base (Tzv, CAS 1226056-71-8), >99%

Item number: LC-T-9753_25mg

Soluble in DMSO
Keywords: Tzv, N-(phenylmethyl)-2-(4-pyrimidinylamino)-4-thiazolecarboxamide
Application: Cell-permeable ROCK inhibitor
CAS 1226056-71-8
MW: 311,36 D
From 134.00€ *
Review
Doramapimod, Free Base (BIRB 796, DB03044, D03736, CAS 285983-48-4), >98%
Doramapimod, Free Base (BIRB 796, DB03044, D03736, CAS...

Item number: LC-D-2744_25mg

Soluble in DMSO at 50 mg/mL, soluble in ethanol at 30 mg/mL, very poorly soluble in water, maximum solubility in plain water is estimated to be about 5-20 µM, buffers, serum, or other additives may increase or decrease the aqueous solubility
Keywords: BIRB-796, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]-urea
Application: p38 MAPK inhibitor
CAS 285983-48-4
MW: 527,66 D
From 128.00€ *
Review
Decitabine, Free Base (5-aza-CdR, 5-aza-dC, AzadC, 5-Aza-2'-deoxycytidine, 5-Azadeoxycytidine, DAC,
Decitabine, Free Base (5-aza-CdR, 5-aza-dC, AzadC,...

Item number: LC-D-3899_50mg

Soluble in DMSO
Keywords: 5-aza-2'-Deoxycytidine, DAC, NSC 127716, 4-amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one
Application: Cytidine analog
CAS 2353-33-5
MW: 228,21 D
From 98.00€ *
Review
NVP-AUY922, Free Base (AUY922, Luminespib, VER-52296, CAS 747412-49-3), >99%
NVP-AUY922, Free Base (AUY922, Luminespib, VER-52296, CAS...

Item number: LC-N-5300_25mg

Soluble in DMSO at 100 mg/mL, soluble in ethanol at 100 mg/mL, very poorly soluble in water, maximum solubility in plain water is estimated to be about 25-50 µM, buffers, serum, or other additives may increase or decrease the aqueous solubility
Keywords: VER 52296, 5-[2,4-dihydroxy-5-(1-methylethyl)phenyl]-N-ethyl-4-[4-(4-morpholinylmethyl)phenyl]-3-isoxazolecarboxamide
Application: Hsp90 Inhibitor
CAS 747412-49-3
MW: 465,54 D
From 101.00€ *
Review
Nilotinib, Free Base (Tasigna, AMN-107, CAS 641571-10-0), >99%
Nilotinib, Free Base (Tasigna, AMN-107, CAS 641571-10-0),...

Item number: LC-N-8207_1g

Soluble in DMSO at 50 mg/mL, very poorly soluble in ethanol, very poorly soluble in water, maximum solubility in plain water is estimated to be about 10-20 µM, buffers, serum, or other additives may increase or decrease the aqueous solubility
Keywords: AMN107,...
Application: Bcr inhibitor, Abl inhibitor
CAS 641571-10-0
MW: 529,52 D
From 92.00€ *
Review
Nintedanib, Ethanesulfonate Salt
Nintedanib, Ethanesulfonate Salt

Item number: LC-N-9055_2g

Solubility: Soluble in DMSO at 25 mg/mL with warming, soluble in ethanol at 8 mg/mL with warming, soluble in water at 25 mg/mL with warming, buffers, serum, or other additives may increase or decrease the aqueous solubility. This research compound is the ethanesulfonate salt form of nintedanib. Nintedanib is an...
Keywords: BIBF1120 Esylate, Intedanib Esylate, Nintedanib Esylate
Application: Antifibrosis, Tyrosine kinase inhibitor
CAS 656247-18-6
MW: 649.76 D
From 82.00€ *
Review
Nintedanib, Free Base
Nintedanib, Free Base

Item number: LC-N-9077_25mg

Solubility: Soluble in DMSO at 25 mg/mL with warming, very poorly soluble in ethanol, very poorly soluble in water, maximum solubility in plain water is estimated to be about 10-20 µM, buffers, serum, or other additives may increase or decrease the aqueous solubility. This product was previously Cat. No. I-9077,...
Keywords: BIBF1120, Intedanib, Vargatef
Application: Antifibrosis, Tyrosine kinase inhibitor
CAS 656247-17-5
MW: 539.62 D
From 82.00€ *
Review
Sorafenib, Free Base (Sorafenib, Bay 43-9006, Nexavar, CAS 284461-73-0), >99%
Sorafenib, Free Base (Sorafenib, Bay 43-9006, Nexavar,...

Item number: LC-S-8599_1g

Soluble in DMSO at 200 mg/mL, soluble in ethanol at 3.3 mg/mL with warming, very poorly soluble in water, maximum solubility in plain water is estimated to be about 10-50 µM, buffers, serum, or other additives may increase or decrease the aqueous solubility
Keywords: Sorafenib, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
Application: Kinase inhibitor
CAS 284461-73-0
MW: 464,82 D
From 79.00€ *
Review
Temsirolimus, >99%
Temsirolimus, >99%

Item number: LC-T-8040_10mg

Soluble in DMSO at 200 mg/mL, soluble in ethanol at 200 mg/mL, very poorly soluble in water, maximum solubility in plain water is estimated to be about 10-20 µM
Keywords: GCCI-779
Application: mTOR inhibitor
CAS 162635-04-3
MW: 1030.29 D
From 92.00€ *
Review
Osimertinib, Methanesulfonate Salt
Osimertinib, Methanesulfonate Salt

Item number: LC-O-7233_25mg

Soluble in DMSO. This research compound is the methanesulfonate salt form of osimertinib. Osimertinib, also known as AZD9291, is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). EGFR TKIs have been used to treat patients with non-small-cell lung cancer (NSCLC) harboring sensitizing...
Keywords: AZD9291, Mereletinib
Application: Antineoplastic, EGFR tyrosine kinase inhibitor
CAS 1421373-66-1
MW: 595.72 D
From 87.00€ *
Review
3 from 12 pages